Evommune, Inc. (EVMN) is a publicly traded the market company. As of October 12, 2026, EVMN trades at $6.15 with a market cap of $226.83M and a P/E ratio of -0.58. EVMN moved -1.52% today. Year to date, EVMN is -63.49%; over the trailing twelve months it is flat. Its 52-week range spans $6.02 to $33.20. Analyst consensus is strong buy with an average price target of $24.00. Rallies surfaces EVMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EVMN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EVMN recently traded at $6.15. Market cap is $226.83M. P/E ratio is -0.58. Revenue is $13.00M.
| Metric | Value |
|---|---|
| Price | $6.15 |
| Market Cap | $226.83M |
| P/E Ratio | -0.58 |
| EPS | $-11.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.20 |
| 52-Week Low | $6.02 |
| Volume | 99.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.00M |
| Net Income | $-68.87M |
| Gross Margin | 0.00% |
12 analysts cover EVMN: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.00.